Cars.com
CARS
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
Teradata Corp
TDC
Workday
WDAY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -35.71%-368.6M | -24.29%-104.4M | -45.51%-97.2M | -40.98%-80.5M | -35.79%-86.5M | -35.53%-271.6M | -25.00%-84M | -31.50%-66.8M | -25.22%-57.1M | -73.10%-63.7M |
Net income from continuing operations | -17.23%-536.8M | -81.58%-198.1M | -123.45%-115.3M | 41.93%-106.9M | -3.01%-116.5M | -44.31%-457.9M | -14.36%-109.1M | 43.30%-51.6M | -156.76%-184.1M | -91.05%-113.1M |
Operating gains losses | 15.13%56.3M | 611.30%81.8M | -95.21%700K | -165.22%-7.5M | -265.49%-18.7M | 631.52%48.9M | 410.81%11.5M | 121.21%14.6M | 271.64%11.5M | 309.26%11.3M |
Depreciation and amortization | 80.00%11.7M | 52.17%3.5M | 57.14%3.3M | 136.36%2.6M | 130.00%2.3M | 47.73%6.5M | 35.29%2.3M | 50.00%2.1M | 57.14%1.1M | 66.67%1M |
Other non cash items | -88.50%8.6M | 119.51%800K | -74.19%800K | -99.06%700K | 350.00%6.3M | 1,526.09%74.8M | -415.38%-4.1M | 244.44%3.1M | 5,623.08%74.4M | 27.27%1.4M |
Change In working capital | -230.30%-17.2M | -226.00%-16.3M | -6.58%-8.1M | -43.48%7.8M | -105.00%-600K | -31.25%13.2M | -184.75%-5M | -216.92%-7.6M | 165.38%13.8M | 650.00%12M |
-Change in prepaid assets | -310.53%-4M | 50.00%-2M | -266.67%-4.5M | 1,050.00%2.3M | -93.33%200K | 186.36%1.9M | -500.00%-4M | 485.71%2.7M | 125.00%200K | 276.47%3M |
-Change in payables and accrued expense | -138.26%-4.4M | -521.43%-11.8M | 90.24%-1.2M | -28.13%6.9M | -85.09%1.7M | -25.81%11.5M | -65.43%2.8M | -392.00%-12.3M | 54.84%9.6M | 208.11%11.4M |
-Change in other current assets | -54.76%-6.5M | 59.09%-1.8M | -212.50%-1.8M | -140.00%-1.2M | -88.89%-1.7M | -425.00%-4.2M | -109.52%-4.4M | 77.78%1.6M | -400.00%-500K | -280.00%-900K |
-Change in other current liabilities | -37.50%1M | ---- | ---- | ---- | ---- | -84.16%1.6M | ---- | ---- | ---- | ---- |
-Change in other working capital | -237.50%-3.3M | -70.00%-1.7M | 100.00%200K | -120.83%-1M | 46.67%-800K | 170.59%2.4M | 91.07%-1M | -98.92%100K | 900.00%4.8M | -66.67%-1.5M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -35.71%-368.6M | -24.29%-104.4M | -45.51%-97.2M | -40.98%-80.5M | -35.79%-86.5M | -35.53%-271.6M | -25.00%-84M | -31.50%-66.8M | -25.22%-57.1M | -73.10%-63.7M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -119.49%-82M | -168.89%-24.2M | -24.05%-19.6M | -114.63%-20.9M | -105.72%-17.3M | 190.61%420.7M | -133.46%-9M | 96.77%-15.8M | 9,626.67%142.9M | 50,533.33%302.6M |
Net PPE purchase and sale | -85.10%-82M | -168.89%-24.2M | -24.05%-19.6M | -158.02%-20.9M | -51.75%-17.3M | -542.03%-44.3M | -172.73%-9M | -953.33%-15.8M | -440.00%-8.1M | -1,800.00%-11.4M |
Net investment purchase and sale | --0 | --0 | --0 | --0 | --0 | 201.66%465M | --0 | --0 | --151M | --314M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -119.49%-82M | -168.89%-24.2M | -24.05%-19.6M | -114.63%-20.9M | -105.72%-17.3M | 190.61%420.7M | -133.46%-9M | 96.77%-15.8M | 9,626.67%142.9M | 50,533.33%302.6M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 228.03%820.4M | 381.73%461.5M | 89.08%258.1M | 147.79%56M | 1,033.33%44.8M | 2,626.26%250.1M | 3,521.43%95.8M | 5,787.50%136.5M | 1,082.61%22.6M | -100.00%-4.8M |
Net issuance payments of debt | 2,400.00%57.5M | --0 | 1,368.00%31.7M | 692.00%14.8M | 540.00%11M | 75.00%-2.5M | 300.00%5M | 0.00%-2.5M | 0.00%-2.5M | 0.00%-2.5M |
Net common stock issuance | 200.50%783.4M | 425.14%476.3M | 61.24%233.8M | 57.60%39.4M | --33.9M | --260.7M | --90.7M | --145M | --25M | --0 |
Proceeds from stock option exercised by employees | 65.52%4.8M | 56.25%2.5M | --0 | ---- | ---- | 2,800.00%2.9M | 633.33%1.6M | --0 | ---- | ---- |
Net other financing activities | -130.00%-25.3M | -1,053.33%-17.3M | -23.33%-7.4M | 58.33%-500K | 95.65%-100K | ---11M | ---1.5M | ---6M | ---1.2M | ---2.3M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 228.03%820.4M | 381.73%461.5M | 89.08%258.1M | 147.79%56M | 1,033.33%44.8M | 2,626.26%250.1M | 3,521.43%95.8M | 5,787.50%136.5M | 1,082.61%22.6M | -100.00%-4.8M |
Net cash flow | ||||||||||
Beginning cash position | 552.14%471.5M | 8.47%508.4M | -11.50%367.1M | 34.63%412.5M | 552.14%471.5M | -90.32%72.3M | 306.15%468.7M | -36.93%414.8M | -56.67%306.4M | -90.32%72.3M |
Current changes in cash | -7.36%369.8M | 11,789.29%332.9M | 162.15%141.3M | -141.88%-45.4M | -125.20%-59M | 159.18%399.2M | 106.50%2.8M | 109.94%53.9M | 319.43%108.4M | 688.19%234.1M |
End cash Position | 78.43%841.3M | 78.43%841.3M | 8.47%508.4M | -11.50%367.1M | 34.63%412.5M | 552.14%471.5M | 552.14%471.5M | 306.15%468.7M | -36.93%414.8M | -56.67%306.4M |
Free cash flow | -42.64%-450.6M | -38.28%-128.6M | -41.40%-116.8M | -55.52%-101.4M | -38.22%-103.8M | -52.39%-315.9M | -31.91%-93M | -57.93%-82.6M | -38.43%-65.2M | -100.80%-75.1M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |